Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 1–50 of 2,679 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03802695	A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	recruiting	Phase 1	300	Orca Biosystems, Inc.INDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT05304208	dENdritic Cell Therapy Combined With SURgEry in Mesothelioma(ENSURE)	recruiting	Phase 1	16	Erasmus Medical CenterOTHER	1	Sep 29, 2026	clinicaltrials